Girotra, Monica

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025

American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Bajaj, M., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 728

Cancer immunotherapy—immune checkpoint blockade and associated endocrinopathies.

Byun, D. J., Wolchok, J. D., Rosenberg, L. M., & Girotra, M. (2017) · Nature Reviews Endocrinology

Cancer Immunotherapy and BiomarkersAdrenal Hormones and Disorders

Cited by 685

Introduction and Methodology: Standards of Care in Diabetes—2025

American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Bajaj, M., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Callaghan, B. C., et al. (2025) · Diabetes Care

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 155

Immune checkpoint inhibitor-associated diabetes: a single-institution experience

Byun, D. J., Braunstein, R., Flynn, J., Zheng, J., Lefkowitz, R. A., Kanbour, S., & Girotra, M. (2020) · Diabetes Care

Cancer Immunotherapy and BiomarkersDiabetes and associated disorders

Cited by 64

Leptin administration does not prevent the bone mineral metabolism changes induced by weight loss

Conroy, R., Girotra, M., Shane, E., McMahon, D. J., Pavlovich, K. H., Leibel, R. L., Rosenbaum, M., & Korner, J. (2011) · Metabolism

Bone health and osteoporosis researchBone Metabolism and Diseases

Cited by 31